Tenon(R) Medical Reports Third Quarter 2025 Financial Results

Core Insights - The company reported record revenue of $1.2 million for Q3 2025, marking a 32% year-over-year increase from $0.9 million in Q3 2024 [1][1][1] - The growth is attributed to record volume in Catamaran® SI Joint Fusion System procedures and the introduction of SImmetry® SI Joint Fusion Product Sales [1][1][1] - The launch of SImmetry®+ alpha in Q4 2025 is expected to enhance the strategic portfolio [1][1][1] - The company has established a foundation for sustained growth through portfolio diversification, commercial expansion, and operational alignment [1][1][1] - Following the quarter end, the company announced a PIPE financing with supportive investors, raising total gross proceeds of $2.85 million [1][1][1]